Clinical Trial Update: Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

View source ↗

Summary

An observational study evaluating the efficacy and safety of zanubrutinib in participants with Waldenström macroglobulinemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeiGene | Conditions: Waldenstrom Macroglobulinemia | Status: RECRUITING